| Product |
CAS |
Molecular formula |
More |
| Sodium (6e)-7-[4-(4-fluorophenyl)-5-(hydroxymethyl)-6-(1-hydroxy-2-pro |
201793-00-2 |
C25H31FNNaO6 |
More |
| 2-Methyl-6-phenylimidazo[1,2-a]pyrazin-3(7h)-one |
19953-58-3 |
C13H11N3O |
More |
| (8R,13s,17r)-13-ethyl-17-ethynyl-17-hydroxy-1,2,4,6,7,8,9,11,12,13,14, |
19914-67-1 |
C21H28O2 |
More |
| 4-Hydroxy propofol |
1988-10-9 |
C12H18O2 |
More |
| Tstepqyqpgenl |
198754-34-6 |
C62H94N16O25 |
More |
| [Tyr9]-β-msh (porcine): (tyr49)-β-lipotropin (41-58) (porcine) |
198281-81-1 |
|
More |
| 3-[(2-Nitrobenzylidene)amino]oxazolidin-2-one |
19687-73-1 |
C10H9N3O4 |
More |
| Naphtho[2,1,8-qra]naphthacene |
196-42-9 |
C24H14 |
More |
| Chlormadinone |
1961-77-9 |
C21H27ClO3 |
More |
| Titanium(3+) sulfate (2:3) |
19495-80-8 |
O12S3Ti2 |
More |
| 2-Oxo-2-(1-pyrenyl)ethyl (3r,5r)-7-{(1s,2s,6r,8s,8ar)-8-[(2,2-dimethyl |
193682-18-7 |
C43H50O7 |
More |
| Semixylenol orange |
19329-67-0 |
C24H23NNa2O9S |
More |
| Moxifloxacin, hydrochloride monohydrate |
192927-63-2 |
C21H27ClFN3O5 |
More |
| 2-Methyl-2-propanyl (2-{[(e)-{5-hydroxy-1-[4-(trifluoromethyl)phenyl]p |
192876-03-2 |
C19H27F3N2O4 |
More |
| (5E)-5-[(2-aminoethoxy)imino]-5-[4-(trifluoromethyl)phenyl]-1-pentanol |
192876-02-1 |
C14H19F3N2O2 |
More |
| (2S)-n-[(4s)-5-{[(2,6-dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diph |
192725-39-6 |
C37H46N4O6 |
More |
| 4-Nitrophenyl anthranilate |
19176-60-4 |
C13H10N2O4 |
More |
| Dibenzo(a,c)triphenylene |
191-68-4 |
C26H16 |
More |
| 10-Oxo mirtazapine (mirtazapine impurity f) |
191546-97-1 |
C17H17N3O |
More |
| 1-Oxo mirtazapine (mirtazapine impurity c) |
191546-96-0 |
C17H17N3O |
More |
